Osteonecrosis in Gaucher disease in the era of multiple therapies: Biomarker set for risk stratification from a tertiary referral center.

Elife · 2023 · PMC10317498 · PMID 37249220

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

While it is not possible to specify overall δ change in serum GlcSph levels as a risk factor for AVN, our study clearly show that serum GlcSph is highly significant risk factor for AVN occurrence.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.